Chong Kun Dang Pharmaceutical Corp (185750):企業の財務・戦略的SWOT分析

◆英語タイトル:Chong Kun Dang Pharmaceutical Corp (185750) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0975
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Chong Kun Dang Pharmaceutical Corp (185750) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Chong Kun Dang Pharmaceutical Corp (CKD Pharma) manufactures, distributes, imports and exports prescription drugs, active pharmaceutical ingredients (APIs), over-the-counter (OTC) drugs, health supplements and consumer health products. Its product portfolio includes prescription products for the entire segment and therapeutic classes; vitamins; shampoos; hair colors; aerosols; mat vaporizers and mosquito coils; and others. The company’s Chong Kun Dang Research Institute is characterized by three independent laboratories, namely, The New Drug Discovery Labs; The Technology Development Labs; and the Bio Research Labs. The company has presence in Japan, Korea, Vietnam and China. CKD Pharma is headquartered in Seoul, South Korea..

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Chong Kun Dang Pharmaceutical Corp – Key Facts
Chong Kun Dang Pharmaceutical Corp – Key Employees
Chong Kun Dang Pharmaceutical Corp – Major Products and Services
Chong Kun Dang Pharmaceutical Corp – History
Chong Kun Dang Pharmaceutical Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Chong Kun Dang Pharmaceutical Corp – Business Description
Chong Kun Dang Pharmaceutical Corp – SWOT Analysis
SWOT Analysis – Overview
Chong Kun Dang Pharmaceutical Corp – Strengths
Chong Kun Dang Pharmaceutical Corp – Weaknesses
Chong Kun Dang Pharmaceutical Corp – Opportunities
Chong Kun Dang Pharmaceutical Corp – Threats
Chong Kun Dang Pharmaceutical Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Chong Kun Dang Pharmaceutical Corp, Key Facts
Chong Kun Dang Pharmaceutical Corp, Key Employees
Chong Kun Dang Pharmaceutical Corp, Major Products and Services
Chong Kun Dang Pharmaceutical Corp, History
Chong Kun Dang Pharmaceutical Corp, Other Locations
Chong Kun Dang Pharmaceutical Corp, Key Competitors
Chong Kun Dang Pharmaceutical Corp, Ratios based on current share price
Chong Kun Dang Pharmaceutical Corp, Annual Ratios
Chong Kun Dang Pharmaceutical Corp, Annual Ratios (Cont...1)
Chong Kun Dang Pharmaceutical Corp, Annual Ratios (Cont...2)
Chong Kun Dang Pharmaceutical Corp, Interim Ratios
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Chong Kun Dang Pharmaceutical Corp, Performance Chart (2014 - 2018)
Chong Kun Dang Pharmaceutical Corp, Ratio Charts
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Chong Kun Dang Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Chong Kun Dang Pharmaceutical Corp (185750):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Saft Groupe SA-エネルギー分野:企業M&A・提携分析
    Summary Saft Groupe SA (Saft), a subsidiary of Total SA, is a designer, developer, and manufacturer of batteries. The company provides non-rechargeable and rechargeable batteries thorough nickel, primary lithium, lithium-ion, and other technologies. It offers systems integration, and various turnkey …
  • Hydro-Quebec-エネルギー分野:企業M&A・提携分析
    Summary Hydro-Quebec is a government-owned energy utility that generates, transmits and distributes electricity. The company specializes in renewable energy generation, using hydro sources and supports the development of electricity using other technologies such as wind energy and biomass. It genera …
  • Pulmatrix Inc (PULM):企業の財務・戦略的SWOT分析
    Summary Pulmatrix Inc (Pulmatrix), formerly Ruthigen Inc is a clinical stage biopharmaceutical company that discovers and develops inhaled therapeutic products intended for prevention and treatment of respiratory diseases and infections. The company develops its pipeline products using its proprieta …
  • Hyperama PLC:企業の戦略・SWOT・財務情報
    Hyperama PLC - Strategy, SWOT and Corporate Finance Report Summary Hyperama PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • International Datacasting Corporation:企業の戦略的SWOT分析
    International Datacasting Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • BioRestorative Therapies Inc (BRTX):企業の財務・戦略的SWOT分析
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • Belvedere International Inc.:企業の戦略・SWOT・財務情報
    Belvedere International Inc. - Strategy, SWOT and Corporate Finance Report Summary Belvedere International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • J. C. Penney Company, Inc.:企業の戦略・SWOT・財務情報
    J. C. Penney Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary J. C. Penney Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bonheur ASA (BON):企業の財務・戦略的SWOT分析
    Summary Bonheur ASA (Bonheur) is an oil and gas investment service provider that offers investment services for various energy sectors. The company invests in renewable energy, cruise, shipping and offshore wind, offshore drilling, and other investments. It operates shipping vessels for transport an …
  • YTL Power International Berhad (YTLPOWR)-エネルギー分野:企業M&A・提携分析
    Summary YTL Power International Berhad (YTL Power), a subsidiary of YTL Corporation Berhad is an investment holding company which is active in the fields of power generation, transmission and supply; water supply and wastewater services; and telecommunications. It undertakes it power generation, tra …
  • CenterPoint Energy Inc (CNP):石油・ガス:M&Aディール及び事業提携情報
    Summary CenterPoint Energy Inc (CenterPoint) is an energy utility company that carries out electric transmission and distribution, and natural gas distribution. It is also involved in natural gas sales and service, pipeline services and other field services. The company sells regulated intrastate na …
  • National Stock Exchange of India Ltd.:企業のM&A・事業提携・投資動向
    National Stock Exchange of India Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Stock Exchange of India Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Eni SpA (ENI):企業の財務・戦略的SWOT分析
    Eni SpA (ENI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • China Sunshine Paper Holdings Company Limited:戦略・SWOT・企業財務分析
    China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Sunshine Paper Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Masimo Corp (MASI):企業の財務・戦略的SWOT分析
    Masimo Corp (MASI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Mondi Plc (MNDI):企業の戦略的SWOT分析
    Mondi Plc (MNDI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Vexim SA (ALVXM):企業の財務・戦略的SWOT分析
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Westinghouse Air Brake Technologies Corporation:企業のM&A・事業提携・投資動向
    Westinghouse Air Brake Technologies Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westinghouse Air Brake Technologies Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business descript …
  • Cleco Corporate Holdings, Llc
    Cleco Corporate Holdings, Llc - Strategy, SWOT and Corporate Finance Report Summary Cleco Corporate Holdings, Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Harland Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Harland Medical Systems Inc (Harland Medical) is a medical equipment provider that offers medical device coatings. The company offers test equipment, coating systems, laser equipment and dispensing equipment. Its products comprise lubricent UV hydrophilic coatings, bacticent antimicrobial co …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆